Product
|
KPV
- Brand:OEM
- Model:10 vials per box
- Purity:99%
- Cas:67727-97-3
- Createtime: 2026-09-08
- Updatetime: 2026-08-27
Product Details
| useage | Fat cell metabolism related cell model experiments |
| deliveryInfo | |
| appearance | White to off?white lyophilized powder |
| aliasen | |
| supplyCapacity | 7/ |
| Form | Lyophilized solid powder |
| harbor | |
| minorder | 1 |
KPV is a minimal active tripeptide fragment cleaved from the C?terminal region of alpha?melanocyte?stimulating hormone. A key experimental advantage lies in its functional decoupling: it preserves the parent molecule’s inflammation?modulating profile, yet loses melanocyte?activating activity linked to pigment generation, making it ideal to separate inflammatory responses from melanogenesis signals in lab assays. Its tiny three?amino?acid skeleton grants favourable cell penetration properties compared with longer regulatory peptides.
Proline?containing short peptide structure brings unique quality?control challenges; dipeptide by?products formed by peptide?bond hydrolysis are the major impurities to monitor. Mass?spectrometry testing confirms exact molecular mass to exclude truncated fragments, and chromatographic separation removes hydrolytic degradation products before batch release. Researchers deploy KPV largely for mucosal barrier investigation, skin inflammation cell models, NF?κB signal?pathway exploration and intestinal epithelium repair?related experimental work.
Because of its short?chain nature, KPV is susceptible to rapid breakdown by various exopeptidases once dissolved into aqueous media. Avoid prolonged storage of reconstituted liquid samples. Prepare stock solution right before experiment and split into small single?use portions. Keep lyophilized substance sealed under frozen dark environment, minimise frequent vial opening to slow down ambient moisture?triggered degradation.
Proline?containing short peptide structure brings unique quality?control challenges; dipeptide by?products formed by peptide?bond hydrolysis are the major impurities to monitor. Mass?spectrometry testing confirms exact molecular mass to exclude truncated fragments, and chromatographic separation removes hydrolytic degradation products before batch release. Researchers deploy KPV largely for mucosal barrier investigation, skin inflammation cell models, NF?κB signal?pathway exploration and intestinal epithelium repair?related experimental work.
Because of its short?chain nature, KPV is susceptible to rapid breakdown by various exopeptidases once dissolved into aqueous media. Avoid prolonged storage of reconstituted liquid samples. Prepare stock solution right before experiment and split into small single?use portions. Keep lyophilized substance sealed under frozen dark environment, minimise frequent vial opening to slow down ambient moisture?triggered degradation.



